1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with methionine in 1 studies
Studies (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Trials (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Recent Studies (post-2010) (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Studies (methionine) | Trials (methionine) | Recent Studies (post-2010) (methionine) |
---|---|---|---|---|---|
195 | 3 | 161 | 27,485 | 530 | 5,020 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arano, Y; Fransisco Lazaro, GG; Hanaoka, H; Kinoshita, M; Nemoto, S; Rokugawa, T; Uehara, T | 1 |
1 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and methionine
Article | Year |
---|---|
(67/68)Ga-labeling agent that liberates (67/68)Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels.
Topics: Animals; Cell Line, Tumor; Drug Stability; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Immunoglobulin Fab Fragments; Isotope Labeling; Kidney; Lysosomes; Male; Methionine; Mice; Molecular Weight; Peptides; Proteolysis; Radioactivity; Structure-Activity Relationship | 2014 |